158 related articles for article (PubMed ID: 32529138)
1. Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes.
Zou Z; Bowen SR; Thomas HMT; Sasidharan BK; Rengan R; Zeng J
Adv Radiat Oncol; 2020; 5(3):434-443. PubMed ID: 32529138
[TBL] [Abstract][Full Text] [Related]
2. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer.
Lin LL; Vennarini S; Dimofte A; Ravanelli D; Shillington K; Batra S; Tochner Z; Both S; Freedman G
Acta Oncol; 2015 Jul; 54(7):1032-9. PubMed ID: 25789715
[TBL] [Abstract][Full Text] [Related]
3. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis.
Kim N; Noh JM; Lee W; Park B; Pyo H
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298711
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Dosimetric Parameters and Clinical Outcomes in Inversely Planned Intensity-Modulated Radiotherapy (IMRT) and Field-in-Field Forward Planned IMRT for the Treatment of Breast Cancer.
Azharuddin SK; Kumar P; S N; Chauhan AK; Kumar P; Nigam J; Mehta A
Cureus; 2022 Jul; 14(7):e26692. PubMed ID: 35949741
[TBL] [Abstract][Full Text] [Related]
7. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
8. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.
Boyce-Fappiano D; Nguyen QN; Chapman BV; Allen PK; Gjyshi O; Pezzi TA; De B; Gomez D; Lin SH; Chang JY; Liao Z; Lee P; Gandhi SJ
Clin Lung Cancer; 2021 Sep; 22(5):e745-e755. PubMed ID: 33707003
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Pencil Beam Scanning Proton- and Photon-Based Techniques for Carcinoma of the Parotid.
Swisher-McClure S; Teo BK; Kirk M; Chang C; Lin A
Int J Part Ther; 2016 Mar; 2(4):525-532. PubMed ID: 31772964
[TBL] [Abstract][Full Text] [Related]
10. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy can achieve lower vertebral bone marrow dose than photon beam therapy during chemoradiation therapy of esophageal cancer.
Zhang Y; Jabbour SK; Zhang A; Liu B; Yue NJ; Biswal NC
Med Dosim; 2021 Autumn; 46(3):229-235. PubMed ID: 33454170
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
Wu CT; Motegi A; Motegi K; Hotta K; Kohno R; Tachibana H; Kumagai M; Nakamura N; Hojo H; Niho S; Goto K; Akimoto T
Jpn J Clin Oncol; 2016 Nov; 46(11):1008-1014. PubMed ID: 27511988
[TBL] [Abstract][Full Text] [Related]
15. A Planning Comparison of IMRT vs. Pencil Beam Scanning for Deep Inspiration Breath Hold Lung Cancers.
Mah D; Yorke E; Zemanaj E; Han Z; Liu H; George J; Lambiase J; Czmielewski C; Lovelock DM; Rimner A; Shepherd AF
Med Dosim; 2022 Spring; 47(1):26-31. PubMed ID: 34426041
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
17. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
[TBL] [Abstract][Full Text] [Related]
18. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Bhangoo RS; DeWees TA; Yu NY; Ding JX; Liu C; Golafshar MA; Rule WG; Vora SA; Ross HJ; Ahn DH; Beamer SE; Jaroszewski DE; Hallemeier CL; Liu W; Ashman JB; Sio TT
Adv Radiat Oncol; 2020; 5(5):871-879. PubMed ID: 33083649
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Yu NY; DeWees TA; Voss MM; Breen WG; Chiang JS; Ding JX; Daniels TB; Owen D; Olivier KR; Garces YI; Park SS; Sarkaria JN; Yang P; Savvides PS; Ernani V; Liu W; Schild SE; Merrell KW; Sio TT
Clin Lung Cancer; 2022 Dec; 23(8):e526-e535. PubMed ID: 36104272
[TBL] [Abstract][Full Text] [Related]
20. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
